相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Allogeneic cord blood regulatory T cells can resolve lung inflammation
Mi-Ae Lyu et al.
CYTOTHERAPY (2023)
Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS
Douglas E. Gladstone et al.
BLOOD ADVANCES (2023)
NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression
Yen-Po Tsao et al.
JOURNAL OF CLINICAL INVESTIGATION (2023)
T cell dysregulation in SLE
Klaus Tenbrock et al.
CLINICAL IMMUNOLOGY (2022)
Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial
Jens Y. Humrich et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Single-cell transcriptome profiling and chromatin accessibility reveal an exhausted regulatory CD4+T cell subset in systemic lupus erythematosus
Chuang Guo et al.
CELL REPORTS (2022)
IFN-?, should not be ignored in SLE
Wenping Liu et al.
FRONTIERS IN IMMUNOLOGY (2022)
Dysregulation and chronicity of pathogenic T cell responses in the pre-diseased stage of lupus
Justus Ohmes et al.
FRONTIERS IN IMMUNOLOGY (2022)
T Cell Abnormalities in the Pathogenesis of Systemic Lupus Erythematosus: an Update
Ping-Min Chen et al.
CURRENT RHEUMATOLOGY REPORTS (2021)
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
Dimitrios Mougiakakos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
Jing He et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Lupus nephritis
Hans-Joachim Anders et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Autoimmunity and organ damage in systemic lupus erythematosus
George C. Tsokos
NATURE IMMUNOLOGY (2020)
Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports
Douglas E. Gladstone et al.
ANNALS OF INTERNAL MEDICINE (2020)
The IL-1 family cytokines and receptors in autoimmune diseases
Paola Migliorini et al.
AUTOIMMUNITY REVIEWS (2020)
IFN-γ Mediates the Development of Systemic Lupus Erythematosus
Wenping Liu et al.
BIOMED RESEARCH INTERNATIONAL (2020)
T-reg cell-based therapies: challenges and perspectives
Caroline Raffin et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis
Jeeba Kuriakose et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Anti-Double-Stranded DNA Isotypes and Anti-C1q Antibody Improve the Diagnostic Specificity of Systemic Lupus Erythematosus
Yu Jia et al.
DISEASE MARKERS (2018)
Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution
Joshua N. Kellner et al.
Oncotarget (2018)
Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective
Vaishali R. Moulton et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
B cells expressing IFN-γ suppress Treg-cell differentiation and promote autoimmune experimental arthritis
Susan A. Olalekan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Mechanisms of kidney injury in lupus nephritis - the role of anti-dsDNA antibodies
Susan Yung et al.
FRONTIERS IN IMMUNOLOGY (2015)
Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease
Simrit Parmar et al.
CYTOTHERAPY (2014)
T Follicular Helper Cell Differentiation, Function, and Roles in Disease
Shane Crotty
IMMUNITY (2014)
Anti-dsDNA Antibody Isotypes in Systemic Lupus Erythematosus: IgA in Addition to IgG Anti-dsDNA Help to Identify Glomerulonephritis and Active Disease
Danilo Villalta et al.
PLOS ONE (2013)
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
Agnes Hartemann et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Increased CD45RA+ FoxP3low Regulatory T Cells with Impaired Suppressive Function in Patients with Systemic Lupus Erythematosus
Xiujun Pan et al.
PLOS ONE (2012)
Cutaneous Manifestations of Systemic Lupus Erythematosus
Luis Uva et al.
AUTOIMMUNE DISEASES (2012)
Phenotype and Function of Natural Killer Cells in Systemic Lupus Erythematosus
Baptiste Hervier et al.
ARTHRITIS AND RHEUMATISM (2011)
Engraftment of Peripheral Blood Mononuclear Cells From Systemic Lupus Erythematosus and Antiphospholipid Syndrome Patient Donors Into BALB-RAG-2-/-IL-2Rγ-/-Mice A Promising Model for Studying Human Disease
Danieli Andrade et al.
ARTHRITIS AND RHEUMATISM (2011)
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS AND RHEUMATISM (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
MECHANISMS OF DISEASE Systemic Lupus Erythematosus
George C. Tsokos
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Mechanisms of tissue injury in lupus nephritis
Tamara K. Nowling et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Fractalkine expression and CD16+ monocyte accumulation in glomerular lesions: association with their severity and diversity in lupus models
Kimihiko Nakatani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Th17 and Natural Treg Cell Population Dynamics in Systemic Lupus Erythematosus
Ji Yang et al.
ARTHRITIS AND RHEUMATISM (2009)
Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus
K. O. Kong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
IL-1β and IL-2 convert human Treg into TH17 cells
Florence Deknuydt et al.
CLINICAL IMMUNOLOGY (2009)
Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high, CD127-/low regulatory T cells in patients with active systemic lupus erythematosus
Ram Kumar Chowdary Venigalla et al.
ARTHRITIS AND RHEUMATISM (2008)
Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: Diagnostic and therapeutic implications
Daniel J. Birmingham et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)
Michael Bonelli et al.
INTERNATIONAL IMMUNOLOGY (2008)
The production of IL-10 by human regulatory T cells is enhanced by IL-2 through a STAT5-responsive intronic enhancer in the IL-10 locus
Kazue Tsuji-Takayama et al.
JOURNAL OF IMMUNOLOGY (2008)
The role of tumor necrosis factor-alpha in systemic lupus erythematosus
Martin Aringer et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus
Xavier Valencia et al.
JOURNAL OF IMMUNOLOGY (2007)
Imbalance of regulatory T cells in human autoimmune diseases
C Dejaco et al.
IMMUNOLOGY (2006)
Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self
S Sakaguchi
NATURE IMMUNOLOGY (2005)
Interferon-γ:: an overview of signals, mechanisms and functions
K Schroder et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus
CG Katsiari et al.
CLINICAL IMMUNOLOGY (2002)
分享论文
